Scope 2018

Strategikon launches Clinical Maestro: 50-75% of outsourcing process costs could be eliminated, says CEO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Furtsef)
(Image: Getty/Furtsef)

Related tags: Management, Cost

Strategikon Pharma has released a new cloud-based solution to help plan, source, and manage clinical programs – with the goal of eliminating paper-based processes.

Clinical Maestro’s capabilities include modeling operational and cost scenarios, forecasting, selecting and managing clinical service providers and clinical contracts.

This is pioneering technology​,” said Anca Copaescu, Strategikon founder and CEO, last week at the SCOPE Summit in Orland, FL.

The platform covers the entire spectrum of planning, budgeting, and contract lifecycle management, she told us.

There are currently no commercial off-the-shelf solutions to automate outsourcing processes. The only tools available are customized, one-off solutions for big pharma. These are primarily bidding portals that are not connected to planning and budgeting and they are not available to the broader market,​” Copaescu said.

The platform features “dual applications​”– one that is sponsor facing and the other for contract research organizations (CROs).

Copaescu said the idea – and hope – is that the platform will be able to eliminate paper. “By paper, I mean the process of creating RFPs, using templates and responding in PDF, and managing excel budgets​,” she explained.

You can safely leave the excel and the paper and the template, and digitize core processes​,” she added, noting that the processes have historically been time-consuming and expensive for both sponsors and CROs.

There is so much potential to cut [costs],​” Copaescu said. “I am estimating between 50 and 75% of outsourcing process costs could be eliminated using Maestro​.”

“It’s really massive because you can create a plan in a minute. You can create an RFP in literally in the push of a button​,” she added. “It’s really dramatic and it’s beautiful too, and that’s why I’m so proud of it​.”

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us

Products

View more

Webinars